Table 3.
Summary of studies that examined replication stress proteomes.
Study | Perturbation | Method | Number of replicates | Number of proteins |
---|---|---|---|---|
Sirbu, J Biol Chem 2013 | Hydroxyurea | iPOND Label-free | 5 | 139* |
Sirbu, J Biol Chem 2013 | Hydroxyurea + ATR inhibitor | iPOND Label-free | 5 | 137* |
Lossaint, Mol Cell 2013 | Hydroxyurea | iPOND Label-free | 3 | n/a |
Dungrawala, Mol Cell 2015 | Hydroxyurea | iPOND-SILAC | 18 | 192 |
Dungrawala, Mol Cell 2015 | Aphidicollin | iPOND-SILAC | 2 | n/a |
Dungrawala, Mol Cell 2015 | Hydroxyurea + ATR inhibitor | iPOND-SILAC | 11 | 151 |
Dungrawala, Mol Cell 2015 | Aphidicolin + ATR inhibitor | iPOND-SILAC | 2 | n/a |
Ribeyre, Cell Reports 2016 | Camptothecin | iPOND-Label-free | 6 | 21 |
Olcina, Tumor Microenvironment 2016 | Hypoxia | iPOND | n/a | n/a |
Raschle, Science 2015 | Psoralen | Chromass-Label-free | 42** | 198*** |
These numbers included proteins that are at undamaged forks since the comparison was to a chase sample.
Additional samples were analyzed containing other inhibitors in addition to psoralen.
112 of these proteins were enriched in a replication-dependent manner.